BioSpherix, LLC

Citing our products is easier than ever: every item on our website has an RRID. Cite easily, promote reproducibility: https://lnkd.in/eR83zwEZ

Happy Thanksgiving from BioSpherix! ???? Please note that our office will be closed on Thursday, November 28th, and Friday, November 29th, in observance of the Thanksgiving holiday. If you need to reach us during this time, feel free to leave a message through our website, and we'll get back to you as soon as possible. Wishing everyone a wonderful and safe holiday season!

?????????????? ???????????????????? ?????????????? ???????????? 2024-2032: ???????????? ???????????????? ????????????. ?????????????? ?????? ???????????? ????????: https://lnkd.in/dh_kX3C3 The Biobank Management Systems Market is witnessing robust growth driven by the increasing demand for biobanking solutions that support research in genomics and personalized medicine. Biobanks play a pivotal role in storing biological samples such as blood, tissue, and DNA along with associated health information to facilitate advanced medical research. However, the Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period as countries enhance their healthcare systems and increase access to biobanking technologies. As a Market Research Analyst with over 10 years of experience in the healthcare sector, I am excited to share insights from our latest report on the Biobank Management Systems Market. This report provides both quantitative and qualitative aspects of the market, examining manufacturers, regional analysis, types, and applications. The biobank management systems market is crucial for the efficient management of biological samples and associated data, which is increasingly important for research in genomics, personalized medicine, and drug development. Valued at approximately USD 76.31 billion in 2023, the market is projected to reach USD 172.53 billion by 2032, growing at a CAGR of 8.8% during this period. Segment-wise growth calculations and forecasts for consumption value are presented for the period 2024-2032, aiding businesses in targeting specific and lucrative market niches for expansion. ???? ???????? ???????????? ?????????? ?????? ???????????? ???? ?????????????? ???????????????????? ??????????????:https://lnkd.in/dh_kX3C3 By Type: Software Solutions, Equipment, Services By Application: Regenerative Medicine, Clinical Research, Life Science Research By Region: North America, Europe, Asia-Pacific, South America, Middle East & Africa By Key Players: Thermo Fisher Scientific, Brooks Automation, QIAGEN, Hamilton Company, biobase, TECAN GROUP, TTP plc, LiCONiC , BioStorage Technologies, Inc., Panasonic North America , Ruroc, Lifeline , LabWare, , TTP - Creative Agency, VWR, part of Avantor , Solentim, MICRONIC, Cryoport Systems, Dataworks Development, Inc. (Freezerworks), BioSpherix, LLC, BioKryo, ASKION Biobanking, FORMULATRIX, LiCONiC, Taylor-Wharton, Biocept, Inc. , Eppendorf , Stericool, BioLiNE, Haier Biomedical UK, BIOBank S.A., MVE Biological Solutions, CRYOPAL #biobank #marketresearch #healthcare #cagr #growthforecast #genomics #personalizedmedicine #clinicalresearch #biotechnology #pharmaceuticals #medicaldevices #innovation

This week, BioSpherix had the privilege of hosting some special guests from our partners at the Breeze Group! We were excited to share our progress and ideas with Colin Lonsdale, Sam Breuning, and Frank Hackett, as well as discuss our many plans for the future. Their insights and ongoing support are invaluable as we continue our journey toward achieving great things together. We look forward to further collaboration and driving innovation forward! #BioSpherix #Partnership #Innovation #Collaboration #FutureForward

It was an honor to be a part of this panel at the LifeSciencesNY "Together'24" meeting today.

The BioSpherix, LLC team is excited to partner with Naomi Ryfun, Ed.D. and the APW school district to help bring make biology fun and exciting for students in NY, the US and around the world! Stay tuned for exciting news in the next few months.

We are excited to share that BioSpherix's President and CEO Syed Ahmed Mustafa has been named to the NSF Piedmont Triad RegenMed Engine's CEO Roundtable! This Roundtable brings together leading figures in regenerative medicine to explore new opportunities within the ecosystem and collaborate on building a strategic partnership portfolio. Ahmed's extensive experience in both business and biotechnology, combined with his entrepreneurial mindset, will be a valuable asset to the PTRME. To learn more about the PTRME or WFIRM, feel free to reach out to us through our website!

#sitc2024 Have you stopped by booth #1019 yet? Timothy Lee, Syed Ahmed Mustafa, and Alicia Henn are having a great time at the Society for Immunotherapy of Cancer (SITC) discussing cutting-edge research and cell processing techniques with fellow science enthusiasts! Pay them a visit to learn how our Xvivo System can benefit your cancer cell and immunotherapy research! Prepare to be wowed!

All set up at the Society for Immunotherapy of Cancer (SITC) and ready to discuss Cytocentric principles at booth #1019! Feel free to stop by - we'd love to chat with you! In vivo, in vitro, GMP, we do it all! How can a BioSpherix system streamline and improve your cell research? #SITC2024 #SITC

BioSpherix President Syed Ahmed Mustafa had another great series of meetings at the Wake Forest Institute for Regenerative Medicine. As he often does, he stopped by the WFIRM Test Bed, a unique facility available to researchers and product developers to experience a multitude of different types of equipment, including the BioSpherix Xvivo System?.? ? Ahmed and WFIRMs Karen Barnes spent some time touring the facility and discussing ways to introduce more people within the Piedmont Triad region to the Test Bed. ? Stay tuned for more exciting news about BioSpherix and our ongoing commitment to support the advancement of regenerative medicine in the NSF Piedmont Triad RegenMed Engine.